EGFR and non-small cell lung carcinoma: Previous studies WJTOG3405, NEJ002, and OPTIMAL indicated that the mPFS of first‐generation EGFR‐TKI as first‐line treatment for advanced EGFR‐mutated NSCLC was only 9–13 months.12, 13, 14